During the past decade, Spitalul Clinic "Sf, Maria" conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 15 clinical trials were completed, i.e. on average, 136.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 7 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Spitalul Clinic "Sf, Maria"" #1 sponsor was "Pfizer" with 6 trials, followed by "Eli Lilly and Company" with 5 trials sponsored, "Amgen" with 4 trials sponsored, "Galapagos NV" with 2 trials sponsored and "Human Genome Sciences Inc." with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Spitalul Clinic "Sf, Maria"" #1 collaborator was "GlaxoSmithKline" with 2 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Chiesi USA, Inc." with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Spitalul Clinic "Sf, Maria"" are "Systemic Lupus Erythematosus" (8 trials), "Rheumatoid Arthritis" (6 trials), "Psoriatic Arthritis" (3 trials), "Lupus Erythematosus, Systemic" (2 trials) and "Ankylosing Spondyloarthritis" (1 trials). Many other conditions were trialed in "Spitalul Clinic "Sf, Maria"" in a lesser frequency.

Most popular intervention types in "Spitalul Clinic "Sf, Maria"" are "Drug" (26 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Baricitinib" (3 trials), "Apremilast 20mg" (2 trials), "Apremilast 30mg" (2 trials) and "Belimumab 1 mg/kg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Spitalul Clinic "Sf, Maria"" are 27 trials for "All" genders.

Currently, there are NaN active trials in "Spitalul Clinic "Sf, Maria"". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Spitalul Clinic "Sf, Maria", undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Spitalul Clinic "Sf, Maria", 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".